Low Angle View Of Cooling Tower Of Nuclear Power Plant Against Sky
Our Work

Latham & Watkins Advises Oklo in Completed Acquisition of Atomic Alchemy

March 5, 2025
Multidisciplinary team from Houston represented the advanced nuclear technology company in the transaction.

Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced that it has closed the acquisition of Atomic Alchemy Inc., a leading innovator in radioisotope production. Atomic Alchemy is pioneering a resilient US-based radioisotope supply chain with its proprietary production and recovery technologies, including its Versatile Isotope Production Reactor (VIPR®) technology.

Latham & Watkins LLP advised Oklo in the transaction with a corporate deal team led by Houston partner Ryan Maierson, with associates John Daywalt, Armaan Bhimani, and Andy Sorensen. Advice was provided on employee benefits and executive compensation matters by Los Angeles/Orange County partner Michelle Carpenter, with associate Aaron Tso; on tax matters by Houston partner Jim Cole, with associate Molly Elkins; on finance matters by Houston partner Craig Kornreich, with associate Max Fin; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Reilly Nelson; on intellectual property matters by New York partner Jeffrey Tochner, with associate Zachary Shufro; on data privacy and cybersecurity matters by Washington D.C. partner Clayton Northouse, with associate Kiara Vaughn; on real estate matters by San Diego partner Stephanie Fontanes; on insurance matters by San Diego partner Drew Gardiner; on securities matters by Houston partner Ryan Maierson, with Chicago associates KC Sands and Ryan Hudson; on energy regulatory matters by Washington, D.C. partner Natasha Gianvecchio, with associate Tanya Khiatani; on government contracts matters by Washington, D.C. partner Kyle Jefcoat; on sanctions and trade control matters by Washington, D.C. counsel Ruchi Gill, with associate Elliot Hecht; and on compliance matters by Washington, D.C. partner Erin Brown Jones, with associate Ashlyn Royall.

Endnotes